Literature DB >> 11216569

Icodextrin effluent leads to a greater proliferation than glucose effluent of human mesothelial cells studied ex vivo.

M A Bajo1, R Selgas, M A Castro, G del Peso, C Diaz, J A Sánchez-Tomero, M Fernandez de Castro, V Alvarez, A Corbí.   

Abstract

OBJECTIVE: To compare the effect of glucose (Glu) and icodextrin (Ico) dialysate on in vitro culture of mesothelial cells (MC) from peritoneal dialysis (PD) patients.
DESIGN: Prospective, controlled comparative study on the effects of two PD solutions.
SETTING: A tertiary-care public university hospital. PATIENTS: Sixteen PD patients regularly using Glu dialysate were asked to collect an 8-hour dwell peritoneal effluent on 2 different days, with an interval shorter than 7 days. In the first collection, 2.27% Glu solution and in the last, 7.5% Ico solution was infused. Human MC were isolated from the nocturnal peritoneal effluent bags and grown ex vivo. MAIN OUTCOME MEASURES: Mesothelial cell proliferative capacity ex vivo.
RESULTS: Mesothelial cells were present in all patient dialysates except that of a single patient's Glu dialysate. The number of MC drained was similar with both solutions. After the initial culture reached confluence, MC were identified in 14 and 12 patients receiving Ico and Glu, respectively. However, in 1 patient using Ico and in 2 using Glu, the MC count at this stage was so low that further subculture could not be performed. Cells from Ico-derived solutions exhibited a higher degree of proliferation than cells from Glu-derived solutions. The morphology of MC was also different. Cells from drained effluent were typical in 11 patients using Glu solution in contrast with 14 patients using Ico. At confluence, the percentages of typical appearance were 50% and 92.9% (p < 0.05) in Glu and Ico respectively.
CONCLUSIONS: Mesothelial cells taken from icodextrin effluent show a greater proliferation ex vivo than those taken from glucose effluent.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11216569

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  11 in total

Review 1.  Mechanisms and interventions in peritoneal fibrosis.

Authors:  Yasuhiko Tomino
Journal:  Clin Exp Nephrol       Date:  2011-09-21       Impact factor: 2.801

Review 2.  An update on peritoneal dialysis solutions.

Authors:  Elvia García-López; Bengt Lindholm; Simon Davies
Journal:  Nat Rev Nephrol       Date:  2012-02-21       Impact factor: 28.314

3.  A peritoneal dialysis regimen low in glucose and glucose degradation products results in increased cancer antigen 125 and peritoneal activation.

Authors:  Caatje Y le Poole; Angelique G A Welten; Piet M ter Wee; Nanne J Paauw; Amina N Djorai; Rob M Valentijn; Robert H J Beelen; Jacob van den Born; Frans J van Ittersum
Journal:  Perit Dial Int       Date:  2011-11-01       Impact factor: 1.756

4.  Interference of peritoneal dialysis fluids with cell cycle mechanisms.

Authors:  Janine Büchel; Maria Bartosova; Gwendolyn Eich; Timo Wittenberger; Ludger Klein-Hitpass; Sonja Steppan; Thilo Hackert; Franz Schaefer; Jutta Passlick-Deetjen; Claus P Schmitt
Journal:  Perit Dial Int       Date:  2014-07-31       Impact factor: 1.756

5.  The peritoneal-renal syndrome.

Authors:  Sharon J Nessim; Joanne M Bargman
Journal:  Nat Rev Nephrol       Date:  2013-03-19       Impact factor: 28.314

Review 6.  Prevention of membrane damage in patient on peritoneal dialysis with new peritoneal dialysis solutions.

Authors:  Mufazzal Ahmad; Hemal Shah; Theodori Pliakogiannis; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2006-09-27       Impact factor: 2.266

7.  Clinical effects of icodextrin in peritoneal dialysis.

Authors:  Trijntje T Cnossen; Constantijn J Konings; Frank M van der Sande; Karel M Leunissen; Jeroen P Kooman
Journal:  NDT Plus       Date:  2008-10

Review 8.  Mesothelial cells in tissue repair and fibrosis.

Authors:  Steven E Mutsaers; Kimberly Birnie; Sally Lansley; Sarah E Herrick; Chuan-Bian Lim; Cecilia M Prêle
Journal:  Front Pharmacol       Date:  2015-06-09       Impact factor: 5.810

9.  Bimodal solutions or twice-daily icodextrin to enhance ultrafiltration in peritoneal dialysis patients.

Authors:  Periklis Dousdampanis; Konstantina Trigka; Joanne M Bargman
Journal:  Int J Nephrol       Date:  2013-01-08

10.  Icodextrin does not impact infectious and culture-negative peritonitis rates in peritoneal dialysis patients: a 2-year multicentre, comparative, prospective cohort study.

Authors:  Andreas Vychytil; César Remón; Catherine Michel; Paul Williams; Ana Rodríguez-Carmona; Belén Marrón; Ed Vonesh; Synke van der Heyden; Jose C Divino Filho
Journal:  Nephrol Dial Transplant       Date:  2008-06-13       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.